DelveInsight's Gene Therapy Reports Archives - DelveInsight

DelveInsight's Gene Therapy Reports

EMA to relocate to Amsterdam; Roche’s prospects; Amgen’s Humira Biosimilar delayed; Purdue’s opio...

EMA to relocate to Amsterdam by March 2019 Results of the Monday's vote for the European Medicines Agency relocation led to the emergence of Amsterdam as the new headquarters, beating the other fin...


Default Blog Image
What are your views on Gene Therapy?

"We used to think that our fate was in our stars, but now we know that, in large measure, our fate is in our genes, "quotes James Watson.This fate that Watson is talking about is contained in ou...


Default Blog Image
Gene Therapy to “Assassinate” HIV virus

Transforming Cells into Molecular AssassinsThe conventional approach to vaccination involves training the immune system to fight an infection. But the Researchers at Scripps Research Institute i...


Default Blog Image
DelveInsight’s Gene Therapy Reports: Launched

Immense Growth Potential in the Gene Therapy Market!DelveInsight has launched its Gene Therapy Report: “Gene Therapy Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landsc...


Default Blog Image
A CRISPR-Cas9 approach for Gene Therapy: The Hot New R&D Field!

Only a hundred and fifty years have passed since Gregor Mendel’s discovery of simple Mendelian inheritance. In a remarkably short amount of time humans have achieved such impressive feats as sequen...


Default Blog Image
Gene Therapy’s Emergence: The “New” approach for Huntington’s disease

Many companies have tried over the years to find a way to reverse the course of crippling neurodegenerative disorders like Huntington’s but have failed. Fortunately, Gene therapy has proven to be ...


Default Blog Image
DelveInsight’s Ophthalmologic disorders based Gene Therapy Reports

Gene Therapy: Eye for the cure! Recent technical advances have led to the demonstration of the molecular basis of various ocular diseases. Gene transfer into ocular tissues has been demonstrated wi...


Default Blog Image
DelveInsight’s Hematological disorders based Gene Therapy Reports

Gene Therapy to “target” Hematological disorders!About Hematological disorders Hematology is the study of blood in health and disease. It includes problems with the red blood cells, white blood ...


Default Blog Image
DelveInsight’s Respiratory disorders based Gene Therapy Reports

Gene Therapy’s “expanding” role in Respiratory disorders!About Respiratory disorders Respiratory disorders encompasses pathological conditions affecting the organs and tissues that make gas exch...


Default Blog Image
DelveInsight’s Immunology based Gene Therapy Reports

Gene Therapy: The “Hope” for Immunologic disorders!About Immunologic disorders Immunological disorders are a dysfunction of the immune system. These disorders cause abnormally low activity or ov...


Editor's Pick
Bone Metastasis Market: A Debilitating Consequence for Many Tumors

In advanced cancer patients, the most common site for the occurrence of metastasis is c...

Evaluating the Role of Digital Therapeutics as an Alternative to Conventional...

Depression is a mental condition characterized by prolonged series of poor moods, loss ...

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia G...

Myasthenia Gravis is an autoimmune disease that causes muscle weakness and fatigue. It ...

Scrutinizing the West Syndrome Market Space from Growth Perspectives

West syndrome is a rare form of neurological disorder, an age-related specific Epilepti...

Recent Inclination of Pharma Companies, Emerging Pipeline Therapies Drive the...

Chronic diseases (CDs) pose a significant challenge to healthcare in the 21st century. ...

ASCO Conference 2021
ASCO Conference 2021

The American Society of Clinical Oncology is a platform that provides a global connection to researchers, pharma companies, and healthcare professions standing against cancer, finding a cure for it.